In late 2021, R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, of the Winship Cancer Institute of Emory University, traveled to Nigeria for 2 weeks as a visiting Fulbright Specialist to train pharmacists on best practices in chemotherapy for cancer treatment. He recounts unforgettable experiences and lasting impressions his counterparts left on him, as well as plans for continuing to help strengthen the capacity of cancer treatment and care in Nigeria.

Related Content: Project Bink Blue Fulbright Specialist Program

Gretchen McNally, PhD, ANP-BC, AOCNP, of The Ohio State University James Cancer Hospital, talks about the language of addiction, recognizing signs of an opioid or substance use disorder, and universal precautions to take through the lens of a case study.

Related Content:

Addiction in Patients With Cancer: Challenges and Opportunities

JL811: Opioid Use Disorders: Experience, Knowledge and Interest Among Oncology Advanced Practice Providers and Pharmacists

JL725: Oncology Advanced Practice Providers: Opportunities to Positively Impact the Opioid Epidemic

Seeing an increase in interventional radiology (IR) referrals and patient wait times, in 2019, an advanced practitioner mobile IR team was started to perform paracentesis and thoracentesis at a major cancer center. Hear from Caitlin Treacy, MS, AGACNP, of Memorial Sloan Kettering Cancer Center, on this advanced practitioner–led team, including hiring, training, and outcomes. This poster received the Outstanding Poster Award at JADPRO Live 2021.

Related Content:

(JL910) Implementation and Impact of an Advanced Practice Provider-Led Bedside Procedural Team at a Major Cancer Institution

The ninth annual JADPRO Live conference wrapped up in October, and Wendy Vogel, MSN, FNP, AOCNP®, Executive Director of APSHO, and Annie Yueh, Editor of JADPRO, take a look back at their favorite moments, interesting statistics, and attendee feedback.

Related Content:

Episode 46: Your True Self: A New Take on How to Combat Burnout

The Mary Pazdur Award for Excellence in Advanced Practice in Oncology

JADPRO Article of the Year: Clinical Trial Design and Drug Approval in Oncology: A Primer for the Advanced Practitioner in Oncology

Cancer-related fatigue (CRF) is one of the most prevalent, debilitating symptoms for patients with cancer. It is also a multifactorial problem for which there is no one solution. Emily A. Lemke, DNP, AGPCNP-BC, AOCNP®, of the Medical College of Wisconsin, summarizes data on one potential option: 2,000 mg of American ginseng daily. She reviews the safety and efficacy, where to source it, and tools to measure fatigue in patients.

Related Content:

Ginseng for the Management of Cancer-Related Fatigue: An Integrative Review. J Adv Pract Oncol 2021;12(4):406–414 Ginseng (American) in About Herbs Ginseng Board of Wisconsin Evaluation of the psychometric properties of the PROMIS Cancer Fatigue Short Form with cancer patients. J Psychosom Res. 2016 Feb;81:9-13 MFSI (Multidimensional Fatigue Symptoms Inventory) ESAS (Edmonton Symptom Assessment System)

This week, we're sharing an episode from Cancer Buzz, the podcast of the Association of Community Cancer Centers (ACCC). While most cancer programs in the United States report that they employ advanced practitioners (APs), they are often not utilized to the full scope of their abilities in clinical research.

In this episode, Beth Faiman, PhD, MSN, APRN-BC, AOCN, FAAN, shares the evolution of the advanced practitioner role at her institution, where APs have a larger voice in the research process and clinical trial protocols, serve as champions to advocate for patients and research staff, and collaborate with their team to promote best practices in clinical trial delivery. Look for more on the Summit findings on the ACCC website.

Margaret Leddy, PA-C, of Duke University Health System, wants to turn the idea of self-care on its head. She starts by asking: Who are you really? By identifying your core values and what you enjoy doing, you can start taking small steps to focus on yourself and thrive even in a setting with high rates of burnout.

Related Content:

The Way of Integrity by Martha Beck

Brené Brown's List of Values

Donald C. Moore, PharmD, BCPS, BCOP, DPLA, of Atrium Health, Levine Cancer Institute, in Concord, North Carolina, talks with host Wendy Vogel, MSN, FNP, AOCNP®, on recent data and strategies for managing adverse events of ibrutinib, acalabrutinib, and zanubrutinib in the treatment of B-cell malignancies.

Related Content:

A Review of the Bruton Tyrosine Kinase Inhibitors in B-Cell Malignancies. J Adv Pract Oncol 2021;12(4):439–447. https://doi.org/10.6004/jadpro.2021.12.4.8

This week, we're sharing an episode from Cancer Buzz, the podcast of the Association of Community Cancer Centers (ACCC). Listen about how oncology advanced practitioners (APs) can play a greater role in clinical research and, according to a recent national study, have a strong interest in doing so. Hear how APs can leverage their deep role in the day-to-day cancer care decisions to improve diversity in clinical trials by bringing their experience to trial design and the accrual process.

In spring 2021, ACCC and Harborside hosted a Virtual Summit to Define on the Role Oncology Advanced Practitioners in Equitable Cancer Care Delivery. Each summit session focused on one specific domain of care delivery—Care Coordination and Communication; Clinical Trials; and Acknowledging and Mitigating Implicit Bias. Look for more on the Summit findings coming soon to the ACCC website.

Related Content:

Understanding Attitudes and Roles of Oncology Advanced Practitioners in the Setting of Cancer Clinical Trials: A Pilot Study. J Adv Pract Oncol 2021;12(5):465–476.

This week, we're sharing an episode from Cancer Buzz, the podcast of the Association of Community Cancer Centers (ACCC).

Increasing diversity and equity in clinical trials will require buy-in and commitment from all stakeholders in the research enterprise. In this episode, Colleen Lewis, MSN, ANP-BC, AOCNP, talks about the critical role oncology advanced practitioners can play in moving the needle on equity and inclusion in cancer clinical trials.

In spring 2021, ACCC and Harborside hosted a Virtual Summit to Define on the Role Oncology Advanced Practitioners in Equitable Cancer Care Delivery. Each summit session focused one specific domain of care delivery—Care Coordination and Communication; Clinical Trials; and Acknowledging and Mitigating Implicit Bias. Look for more on the Summit findings coming soon to the ACCC website.